Kyoto, Japan

Shogo Hoashi

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Arkray, Inc.. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shogo Hoashi. Retrieved from https://idiyas.com/inventor/shogo-hoashi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shogo Hoashi: Innovator in Glucose Sensing Technology

Introduction

Shogo Hoashi is a prominent inventor based in Kyoto, Japan. He has made significant contributions to the field of glucose sensing technology. His innovative work has led to the development of a unique glucose sensor that enhances the accuracy of glucose concentration measurements.

Latest Patents

Shogo Hoashi holds 1 patent for his groundbreaking invention, a glucose sensor. This sensor is capable of measuring glucose concentration even when type FAD-GDH (flavin adenine dinucleotide-glucose dehydrogenase) and a ruthenium compound are used in combination. The design includes an insulative substrate, an electrode system with a working electrode and a counter electrode, and a reagent layer that contains type FAD-GDH, a ruthenium compound, and PMS (phenazine methosulfate).

Career Highlights

Shogo Hoashi is associated with Arkray, Inc., a company known for its advancements in medical technology. His work at Arkray has focused on improving glucose monitoring systems, which are essential for diabetes management.

Collaborations

Shogo Hoashi collaborates with Takehiro Yamaguchi, contributing to the development of innovative solutions in glucose sensing technology.

Conclusion

Shogo Hoashi's contributions to glucose sensing technology exemplify the impact of innovation in healthcare. His work continues to influence the field and improve the lives of individuals managing diabetes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…